The hybrid technique of PET/CT has significantly impacted the imaging and management of HNSCC since its introduction in 2001 and has become the technique of choice for imaging of this cancer. Diagnostic FDG-PET/CT is useful for identification of an unknown primary tumor, delineation of extent of primary tumor, detection of regional lymph node involvement even in a normal-sized node, detection of distant metastases and occasional synchronous primary tumor, assessment of therapy response, and long-term surveillance for recurrence and metastases. The role of PET/CT is evolving in radiation therapy planning. Combined diagnostic PET/CT provides the best anatomic and metabolic in vivo information for the comprehensive management of HNSCC.
CITATION STYLE
Subramaniam, R. M., Truong, M., Peller, P., Sakai, O., & Mercier, G. (2010, April). Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.A1760
Mendeley helps you to discover research relevant for your work.